适应性免疫细胞与原发性舍格伦综合征的相关性

doi:10.13701/j.cnki.kqyxyj.2022.02.001

摘要/Abstract

摘要： 原发性舍格伦综合征(primary Sjögren's syndrome,pSS)是一种自身免疫性疾病,发病过程伴随适应性免疫应答的改变。了解其发病过程适应性免疫细胞的病理生理学改变,有助于进一步寻找免疫治疗的靶点。本文就目前国内外研究现状,对pSS和适应性免疫细胞的相关性作一综述。

关键词: 原发性舍格伦综合征, 适应性免疫细胞, T细胞, B细胞

Abstract: Primary Sjögren's syndrome (pSS) is an autoimmune disease whose pathogenesis changes with adaptive immunity. Learning about the pathophysiological changes of adaptive immune cells in pSS helps us further find immune therapy targets. This paper reviews the current research on the association of pSS and adaptive immune cells at home and abroad.

Key words: primary Sjögren's syndrome, adaptive immune cells, T cells, B cells

陈江, 林彦君. 适应性免疫细胞与原发性舍格伦综合征的相关性[J]. 口腔医学研究, 2022, 38(2): 99-103.

CHEN Jiang, LIN Yanjun. Association of Adaptive Immune Cells and Primary Sjögren's Syndrome[J]. Journal of Oral Science Research, 2022, 38(2): 99-103.

参考文献

[1] Spachidou MP, Bourazopoulou E, Maratheftis CI, et al. Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome [J]. Clin Exp Immunol, 2007, 147(3):497-503.
[2] Mitsias DI, Tzioufas AG, Veiopoulou C, et al. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren's syndrome [J]. Clin Exp Immunol, 2002, 128(3): 562-568.
[3] Karabiyik A, Peck AB, Nguyen CQ. The important role of T cells and receptor expression in Sjögren's syndrome [J]. Scand J Immunol, 2013, 78(2): 157-166.
[4] Maehara T, Moriyama M, Hayashida JN, et al. Selective localization of T helper subsets in labial salivary glands from primary Sjögren's syndrome patients [J]. Clin Exp Immunol, 2012, 169(2): 89-99.
[5] Hartenstein B, Teurich S, Hess J, et al. Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB [J]. EMBO J, 2002, 21(23): 6321-6329.
[6] Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells [J]. Cell, 1997, 89(4): 587-596.
[7] Brayer JB, Cha S, Nagashima H, et al. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome [J]. Scand J Immunol, 2001, 54(1-2): 133-140.
[8] Gao J, Killedar S, Cornelius JG, et al. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease [J]. J Autoimmun, 2006, 26(2): 90-103.
[9] Crane Isabel J, Forrester John V. Th1 and Th2 lymphocytes in autoimmune disease [J]. Crit Rev Immunol, 2005, 25(2): 75-102.
[10] Ciccia F, Guggino G, Rizzo A, et al. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome [J]. Ann Rheum Dis, 2012, 71(2): 295-301.
[11] Fei Y, Zhang W, Lin D, et al. Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren's syndrome [J]. Clin Rheumatol, 2014, 33(4): 523-529.
[12] Katsifis GE, Rekka S, Moutsopoulos NM, et al. Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis [J]. Am J Pathol, 2009, 175(3): 1167-1177.
[13] Luckheeram RV, Zhou R, Verma AD, et al. CD4⁺T cells: differentiation and functions [J]. Clin Dev Immunol, 2012, 2012: 925135.
[14] Li L, He J, Zhu L, et al. The clinical relevance of IL-17-producing CD4⁺CD161⁺ cell and its subpopulations in primary Sjögren's syndrome [J]. J Immunol Res, 2015, 2015: 307453.
[15] Alunno A, Carubbi F, Bistoni O, et al. CD4^-CD8^-T-cells in primary Sjögren's syndrome: Association with the extent of glandular involvement [J]. J Autoimmun, 2014, 51: 38-43.
[16] Hirahara K, Nakayama T. CD4⁺ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm [J]. Int Immunol, 2016, 28(4): 163-171.
[17] Sarigul M, Yazisiz V, Bassorgun CI, et al. The numbers of Foxp3⁺ Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjögren's syndrome [J]. Lupus, 2010, 19(2): 138-145.
[18] Christodoulou MI, Kapsogeorgou EK, Moutsopoulos NM, et al. Foxp3⁺ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors [J]. Am J Pathol, 2008, 173(5): 1389-1396.
[19] van den Berg WB, McInnes IB. Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics [J]. Semin Arthritis Rheum, 2013, 43(2): 158-170.
[20] Lin X, Rui K, Deng J, et al. Th17 cells play a critical role in the development of experimental Sjögren's syndrome [J]. Ann Rheum Dis, 2015, 74(6): 1302-1310.
[21] Vinuesa CG, Linterman MA, Yu D, et al. Follicular helper T cells [J]. Annu Rev Immunol, 2016, 34: 335-368.
[22] Pontarini E, MurrayBrown W, Croia C, et al. Enrichment of T follicular-helper cells (TFH) and exclusion of t follicular-regulatory cells (TFR) from ectoPIC germinal centers in salivary glands of sjogren's syndrome patients [J]. Ann Rheum Dis, 2017, 76(Suppl 2): 180-180.
[23] Fonseca VR, Romão VC, Agua-Doce A, et al. The ratio of blood T follicular regulatory cells to T follicular helper cells marks ectopic lymphoid structure formation while activated follicular helper T cells indicate disease activity in primary Sjögren's syndrome [J]. Arthritis Rheumatol, 2018, 70(5):774-784.
[24] Verstappen GM, Nakshbandi U, Mossel E, et al. Is the T follicular regulatory/T follicular helper cell ratio in blood a biomarker for ectopic lymphoid structure formation in Sjögren's syndrome? [J]. Arthritis Rheumatol, 2018, 70(8):1354-1355.
[25] Szabo K, Papp G, Barath S, et al. Follicular helper T cells may play an important role in the severity of primary Sjögren's syndrome [J]. Clin Immunol, 2013, 147(2): 95-104.
[26] King IL, Mohrs M. IL-4 producing CD4⁺ T cells in reactive lymph nodes during helminth infection are T follicular helper cells [J]. J Exp Med, 2009, 206(5):1001-1007.
[27] Pontarini E, Murray-Brown WJ, Croia C, et al. Unique expansion of IL-21⁺ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma [J]. Ann Rheum Dis, 2020, 79(12): 1588-1599.
[28] Gao CY, Yao Y, Li L, et al. Tissue-resident memory CD8⁺ T cells acting as mediators of salivary gland damage in a murine model of Sjögren's syndrome [J]. Arthritis Rheumatol, 2019, 71(1): 121-132.
[29] Mingueneau M, Boudaoud S, Haskett S, et al. Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation [J]. J Allergy Clin Immunol, 2016, 137(6): 1809-1821.e12.
[30] Tasaki S, Suzuki K, Nishikawa A, et al. Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren's syndrome [J]. Ann Rheum Dis, 2017, 76(8):1458-1466.
[31] Caldeira-Dantas S, Furmanak T, Smith C, et al. The chemokine receptor CXCR3 promotes CD8⁺ T cell accumulation in uninfected salivary glands but is not necessary after murine cytomegalovirus infection [J]. J Immunol, 2018, 200(3): 1133-1145.
[32] Barr JY, Wang X, Meyerholz DK, et al. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome [J]. Immunol Cell Biol, 2017, 95(8): 684-694.
[33] Maruyama M, Lam KP, Rajewsky K. Memory B-cell persistence is independent of persisting immunizing antigen [J]. Nature, 2000, 407(6804): 636-642.
[34] Giesecke C, Frölich D, Reiter K, et al. Tissue distribution and dependence of responsiveness of human antigen-specific memory B cells [J]. J Immunol, 2014,192(7): 3091-3100.
[35] Steiniger B, Timphus EM, Jacob R, et al. CD27⁺ B cells in human lymphatic organs: re-evaluating the splenic marginal zone [J]. Immunology, 2005, 116(4): 429-442.
[36] Amft N, Curnow SJ, Scheel-Toellner D, et al. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome [J]. Arthritis Rheum, 2001, 44(11): 2633-2641.
[37] Salomonsson S, Larsson P, Tengnér P, et al. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome [J]. Scand J Immunol, 2002, 55(4): 336-342.
[38] Manzo A, Vitolo B, Humby F, et al. Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint [J]. Arthritis Rheum, 2008, 58(11): 3377-3387.
[39] Rupprecht TA, Plate A, Adam M, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis [J]. J Neuroinflammation, 2009, 6: 42.
[40] Sáez de Guinoa J, Barrio L, Mellado M, et al. CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics [J]. Blood, 2011, 118(6):1560-1569.
[41] Fazilleau N, McHeyzer-Williams LJ, Rosen H, et al. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding [J]. Nat Immunol, 2009, 10(4): 375-384.
[42] Moisini I, Davidson A. BAFF: a local and systemic target in autoimmune diseases [J]. Clin Exp Immunol, 2009, 158(2): 155-163.
[43] Szyszko EA, Brokstad KA, Oijordsbakken G, et al. Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival [J]. Arthritis Res Ther, 2011, 13(1): R2.
[44] Tengnér P, Halse AK, Haga HJ, et al. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome[J]. Arthritis Rheum, 1998, 41(12): 2238-2248.
[45] Aqrawi LA, Brokstad KA, Jakobsen K, et al. Low number of memory B cells in the salivary glands of patients with primary Sjögren's syndrome [J]. Autoimmunity, 2012, 45(7): 547-555.
[46] Szabó K, Papp G, Szántó A, et al. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus [J]. Clin Exp Immunol, 2016, 183(1): 76-89.
[47] Blair PA, Noreña LY, Flores-Borja F, et al. CD19⁺CD24^hiCD38^hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients [J]. Immunity, 2010, 32(1):129-140.
[48] Candando KM, Lykken JM, Tedder TF. B10 cell regulation of health and disease [J]. Immunol Rev, 2014, 259(1): 259-272.
[49] Menon M, Blair PA, Isenberg DA, et al. A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus[J]. Immunity, 2016, 44(3): 683-697.
[50] Lemoine S, Morva A, Youinou P, et al. Human T cells induce their own regulation through activation of B cells [J]. J Autoimmun, 2011, 36(3-4): 228-238.
[51] Fogel O, Rivière E, Seror R, et al. Role of the IL-12/IL-35 balance in patients with Sjögren syndrome [J]. J Allergy Clin Immunol, 2018, 142(1): 258-268.e5.